Glad to share our work entitled "Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers With Different MET Exon 14 Skipping Mutations" published in @JTOonline @DrMarkAwad Dr. Chaft and Dr. Agrawal https://t.co/pOiPoseNuq

Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers with Different MET Exon 14 Skipping Mutations🧬 https://t.co/nBrjNuvGqY This study evaluated NSCLC cases with MET exon 14 skipping (METex14) mutations using DNA-based

Congratulations to Dr. Jamie Chaft @ChaftJamie and co-investigators on the NeoADAURA clinical trial of neoadjuvant osimertinib in EGFR mutant lung cancer. #ASCO25 @EGFRResisters @MSKCancerCenter

Wonderful presentation from Dr. Alissa Cooper @alissajcooper on SEZ6 ADC ABBV-706 showing efficacy in diverse neuroendocrine tumors @MSKCancerCenter

Congratulations to Charlie Rudin & DeLLphi-304 investigators on this practice-changing trial for our patients with small cell lung cancer @MSKCancerCenter Tarlatamab in SCLC after Platinum-Based Chemotherapy | New England Journal of Medicine

Congratulations to Kathryn Arbour @KCArbourMD and colleagues showing activity of BMS-986504 in MTAP-deleted solid tumors, including lung and pancreas cancer. @MSKCancerCenter

Thank you to our outstanding thoracic oncology team of physicians and reach staff @MSKCancerCenter for making such an impact on patient care through clinical trials #ASCO2025

Congratulations to Dr. Helena Yu and colleagues on their wonderful #ASCO2025 presentation on zipalertinib for patients with EGFR exon 20 insertion lung cancer. @Exon20Group @EGFRResisters @MSKCancerCenter

We're excited to share that Dr. Andy Minn will return to MSK as the inaugural Chair of MSK’s new Immuno-Oncology Program in August. This is a full-circle moment for Dr. Minn, a renowned physician-scientist, who completed his postdoctoral training with Dr. Joan Massagué,

Congrats to Mark G. Kris, Kenneth Offit, David G. Pfister, and @szusmani on being inducted into the 13th Giants of Cancer Care® class by @OncLive! This award honors leading physicians who are advancing #cancerresearch. @MSKCancerCenter Learn more: https://t.co/FcZdjNUeBa

Congratulations to Dr. Mark Kris @MSKCancerCenter for being named a Giant of Cancer Care for his many contributions to advancing the field of thoracic oncology! @OncLive #lcsm https://t.co/t3zlVWvdcp via @onclive

Join MSK thoracic medical oncologist Dr. Kathryn Arbour (@KCArbourMD) for a plenary session titled “Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer

In her plenary session at #AACR25, @AndreaCercek shared that PD-1 #immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers. Learn more: https://t.co/dyCm86ou38 @AACR

Congratulations to the MSK-IMPACT team at MSK for receiving the American Association for Cancer Research (AACR) Team Science Award. The team, led by @MFBerger1, @DSolit, and @MLadanyi, is recognized for its pivotal advances in clinical genomic sequencing that have transformed

Ph1 trial of zoldonrasib (RMC-9805), an oral KRAS G12D inhibitor in pts w/ #NSCLC showed ORR of 61%. Side effects primarily gastro-intestinal. Great to see new options for this pt group. @KCArbourMD @MSKCancerCenter #AACR25 @KRASKickers

Now online in @CD_AACR: Antitumor Activity of Vebreltinib & Characterization of Clinicogenomic Features in Tumors with MET Rearrangements - by Seshiru Nakazawa, @pecci_federica1, Igor Odintsov, Pasi Janne, @DrMarkAwad, et al. https://t.co/N7ppAos7IE @DanaFarber @MSKCancerCenter

‼️📣 Calling ALL patients with Lung Cancer📣 ‼️ Your candid opinions will help guide the future! I am conducting with @IshwariaMD @DevikaDasMD a de- identified survey addressing barriers to clinical trial accrual. SURVEY LINK and Preamble BELOW 👇🏽 https://t.co/iHYATmLmai

Register now for LCRF's 2024 Scientific Symposium: Monday, Nov. 4, 3-6pm ET. Our experts will lead a live, virtual discussion on Lung Cancer: Addressing Unmet Needs. Sign up at https://t.co/vMczM2VhVE. #LungCancer #LCAM

Joining us are speakers and panelists @DrMarkAwad @BrendonStilesMD @ZieglerColleen @LaurenByersMD @HosseinBorghaei, Joseph Greer, PhD; Don Nguyen, PhD, BSc; and Kathryn O'Donnell, PhD; with chat moderator @ipreeshagul. Excited to hear from these experts!

👏 Congratulations to Dr. Deb Schrag, Chair of the @MSK_DeptOfMed, and Dr. @studerl, Director of the Center for Stem Cell Biology at MSK, who were elected to the @theNAMedicine, one of the highest honors bestowed upon scientists worldwide. Learn more: https://t.co/N2NdRJv4TE